Disc Medicine (IRON) has made great progress in advancing its lead candidate for its pipeline known as bitopertin for the treatment of patients with erythropoietic protoporphyria [EPP] and X-linked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results